Combivir is lamivudine and zidovudine; Epzicom is lamivudine and abacavir; Triumeq is abacavir, dolutegravir and lamivudine; Trizivir is lamivudine, abacavir and zidovudine
- TRADE NAMES: Combivir (ViiV); Epivir (ViiV); Epzicom (ViiV); Triumeq (ViiV); Trizivir (ViiV)
- INDICATIONS: HIV progression
- SYNONYM: 3TC
- CLASS: Antiretroviral, Nucleoside analog reverse transcriptase inhibitor
- HALF-LIFE: 5–7 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Emtricitabine, Trimethoprim
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on this DRUG REVIEW ARTICLE tab (above) to see a review of lamivudine in the Taylor & Francis journal Expert Opinion on Drug Safety
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
